Gary Thomas
Department of Internal Medicine, Division of Angiology, Medical University Graz, Austria.
Vasa. 2014 Jul;43(4):245-51. doi: 10.1024/0301-1526/a000359.
Cancer is a highly thrombophilic entity leading to a high rate of symptomatic and even asymptomatic venous thromboembolic (VTE) events in patients suffering from malignant disease. As VTE events have impact on survival and can be reduced significantly by anticoagulant treatment, guidelines on prophylaxis of these events by means of anticoagulation exist from various societies. Purpose of this review is to give a concise overview of current possibilities for prophylaxis and also for the therapy of VTE events in cancer patients.
癌症是一种具有高度血栓形成倾向的疾病，会导致恶性疾病患者出现较高比例的有症状甚至无症状的静脉血栓栓塞（VTE）事件。由于VTE事件会影响生存，且通过抗凝治疗可显著降低其发生率，因此各协会都制定了关于通过抗凝预防这些事件的指南。本综述的目的是简要概述目前癌症患者预防和治疗VTE事件的可行方法。
